InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) went up by 11.11% from its latest closing price compared to the recent 1-year high of $10.95. The company’s...
InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) went up by 6.29% from its latest closing price compared to the recent 1-year high of $10.95. The company’s...
InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) went up by 5.30% from its latest closing price compared to the recent 1-year high of $11.98. The company’s...
InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) went down by -4.03% from its latest closing price compared to the recent 1-year high of $11.98. The company’s...
InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) went up by 5.93% from its latest closing price compared to the recent 1-year high of $11.98. The company’s...
InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) went down by -8.57% from its latest closing price compared to the recent 1-year high of $11.98. The company’s...
InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) went down by -3.62% from its latest closing price compared to the recent 1-year high of $16.20. The company’s...
InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) went down by -44.70% from its latest closing price compared to the recent 1-year high of $16.20. The company’s...